Sturm, Ruger & Company (RGR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 net sales reached $122.3M, up 1.2% year-over-year, but diluted EPS fell to $0.28 from $0.42 due to lower production and margin pressure.
Nine-month 2024 net sales were $389.9M, down from $413.2M in 2023, with EPS at $1.15, down from $2.13.
Net income for Q3 2024 was $4.7M, down 36.2% from $7.4M in Q3 2023; nine-month net income was $20.1M, down 47.1% year-over-year.
New products accounted for 31% of firearm sales in Q3 and 31.2% in the first nine months, supporting market share gains.
Inventory levels decreased by 125,000 units over the past year, positioning the company for the stronger fall/winter season.
Financial highlights
Cash and short-term investments totaled $96M as of September 28, 2024.
Current ratio stood at 4.5 to 1, with no debt.
Gross margin for Q3 2024 was 18.5%, down from 20.5% in Q3 2023; EBITDA for Q3 2024 was $9.9M (8.1% margin), down from $13.3M (11.0%).
Generated $35.5M in operating cash flow and spent $17.2M on capital expenditures in the first nine months.
Returned $39.3M to shareholders YTD: $10.0M in dividends, $29.3M in share repurchases.
Outlook and guidance
Capital expenditures for 2024 are expected to total approximately $20M, focused on new products and manufacturing upgrades.
Q4 production, especially for Marlin rifles, will be maximized, but backlog will extend into 2025.
No aggressive promotional activity planned for Q4, but may adjust strategy in 2025 depending on market conditions.
Forward-looking statements caution on market demand, sales levels, litigation, and regulatory risks.
Positioned to increase production for the stronger fall and winter selling seasons to meet pent-up demand.
Latest events from Sturm, Ruger & Company
- Board refresh and Ruger 2030 strategy drive strong returns and disciplined growth.RGR
Proxy filing24 Mar 2026 - Ruger’s board rebuffed Beretta’s control efforts, reinforcing governance and shareholder protections.RGR
Proxy Filing10 Mar 2026 - Beretta’s bid for board control prompts defensive measures and governance refreshment.RGR
Proxy Filing9 Mar 2026 - Board composition refreshed with new independent directors amid shareholder proposals.RGR
Proxy Filing3 Mar 2026 - Sales growth and innovation offset market declines, but profitability fell year-over-year.RGR
Q4 20252 Mar 2026 - Q2 sales and profit declined, but new products and efficiency gains support future growth.RGR
Q2 20242 Feb 2026 - Net income up 9.7% on flat sales, strong liquidity, and rising CapEx for innovation.RGR
Q1 202524 Dec 2025 - Q4 sales and earnings rebounded on new product strength and market share gains.RGR
Q4 202423 Dec 2025 - Board recommends director elections, auditor ratification, and executive pay policies for 2025.RGR
Proxy Filing1 Dec 2025